Skip to content
Screener

Total debt at other companies

Bristol-Myers Squibb logo
Bristol-Myers SquibbBMY
$43.33B-12.3%
Alkermes logo
AlkermesALKS
$1.57B+2,064%
MapLight Therapeutics, Inc. logo
MapLight Therapeutics, Inc.MPLT
$5.59M
Alto Neuroscience logo
Alto NeuroscienceANRO
$20.88M-17.2%
Acadia Pharmaceuticals logo
Acadia PharmaceuticalsACAD
$73.85M+31.2%
Xenon Pharmaceuticals logo
Xenon PharmaceuticalsXENE
$6.42M-26.4%

Other financials

Income statement

See full
Net income-$19.1M-259%
EPS (diluted)-$0.67+95.5%

Balance sheet

See full
Cash & equivalents$320.7M
Total equity$378.7M+481%
Total assets$393.5M

Cash flow

See full
Operating cash flow-$23.3M-187%
CapEx$32.0K+52.4%
Free cash flow-$23.3M-186%

Valuation

See full
Market cap$1.38B+309%
Enterprise value$1.06B

Returns & leverage

See full
Return on equity-27.9%
Debt / equity
Current ratio35.7×

Where this comes from

Computed from long term debt + current portion long term debt + short term borrowings + operating lease liabilities + finance lease liabilities + financing obligations: $3.47M.

The source filing: LB Pharmaceuticals Inc’s 10-Q, filed May 12, 2026. Open the filing →

Filed
May 12, 2026, 4:31 PM EDT
Fiscal quarter
Q1 FY2026
Calendar quarter
Q1 2026
Accession
0001193125-26-219607

FAQ

What is LB Pharmaceuticals Inc's total debt?
LB Pharmaceuticals Inc (LBRX) reported total debt of $3.47M in Q1 2026.
What does total debt mean?
Total debt represents the aggregate sum of all interest-bearing financial obligations, including short-term borrowings, the current portion of long-term debt, and long-term debt instruments. It also encompasses capitalized lease liabilities and other debt-like financing arrangements that require fixed repayment schedules. This metric serves as a comprehensive indicator of a company's total financial leverage and its reliance on external capital providers.

Ask your AI about LB Pharmaceuticals Inc's total debt.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude